AMPHINEX Trademark

Trademark Overview

On Friday, October 26, 2012, a trademark application was filed for AMPHINEX with the United States Patent and Trademark Office. The USPTO has given the AMPHINEX trademark a serial number of 79124873. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Tuesday, February 9, 2021. This trademark is owned by PCI Biotech AS. The AMPHINEX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for light-induced therapies, namely, pharmaceutical preparations for the treatment of cancer; chemical preparations used in connection with cancer treatment; vaccines

[Medical apparatus and instruments for use in connection with cancer treatment, namely, lighting apparatus and instruments; Medical apparatus and instruments for drug delivery purposes, namely, lighting apparatus and instruments]
amphinex

General Information

Serial Number79124873
Word MarkAMPHINEX
Filing DateFriday, October 26, 2012
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateTuesday, February 9, 2021
Registration Number4457049
Registration DateTuesday, December 31, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for light-induced therapies, namely, pharmaceutical preparations for the treatment of cancer; chemical preparations used in connection with cancer treatment; vaccines
Goods and Services[Medical apparatus and instruments for use in connection with cancer treatment, namely, lighting apparatus and instruments; Medical apparatus and instruments for drug delivery purposes, namely, lighting apparatus and instruments]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 19, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, February 9, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePCI Biotech AS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNO
Party NamePCI Biotech AS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNO
Party NamePCI Biotech AS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNO

Trademark Events

Event DateEvent Description
Tuesday, February 19, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 4, 2013NON-FINAL ACTION WRITTEN
Thursday, February 14, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, February 23, 2013APPLICATION FILING RECEIPT MAILED
Tuesday, February 26, 2013ASSIGNED TO EXAMINER
Monday, March 25, 2013REFUSAL PROCESSED BY IB
Tuesday, August 27, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 5, 2013REFUSAL PROCESSED BY MPU
Tuesday, March 5, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 27, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 28, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 28, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, November 16, 2013NEW REPRESENTATIVE AT IB RECEIVED
Sunday, December 22, 2013NEW REPRESENTATIVE AT IB RECEIVED
Thursday, September 12, 2013ASSIGNED TO LIE
Thursday, September 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 25, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 15, 2013PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2013NOTIFICATION PROCESSED BY IB
Friday, May 30, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 31, 2013REGISTERED-PRINCIPAL REGISTER
Friday, January 31, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 31, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 30, 2014FINAL DISPOSITION PROCESSED
Friday, June 20, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 31, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, June 29, 2020TEAS SECTION 71 RECEIVED
Thursday, November 12, 2020ASSIGNED TO PARALEGAL
Thursday, November 26, 2020POST REGISTRATION ACTION MAILED - SEC.71
Thursday, November 4, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, November 11, 2022INTERNATIONAL REGISTRATION RENEWED
Monday, February 8, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, February 9, 2021REGISTERED - PARTIAL SEC 71 ACCEPTED
Tuesday, February 9, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, October 9, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, November 4, 2021INVALIDATION PROCESSED
Sunday, December 5, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Saturday, October 8, 2022LIMITATION OF GOODS RECEIVED FROM IB
Thursday, November 3, 2022LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, September 26, 2025NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 31, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Related Keywords

amphinex apparatus instruments namely cancer treatment preparations connection medical pharmaceutical lighting